| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c8ae0e9d34fc354d561ad7696b1077 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7f4cf26e3863ec50b6d543ae2ab13e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f1c9dacd3ee733db58287f2cced5be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5c2fb35e989230606019e742954bbf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2eb3d08fa73cd3d0078a8aa14068faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a590a3f32d0797be3a2ccab97849132 |
| publicationDate |
2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190075594-A |
| titleOfInvention |
Novel drug delivery composition and pharmaceutical composition for treating gm1 gangliosidosis comprising the same |
| abstract |
The present invention relates to a drug delivery composition or a recombinant protein having a specific structure and a gene transfer composition containing the same as an effective ingredient. Further, the present invention relates to a pharmaceutical composition for treating GM1 ganglioside, comprising the above composition as an active ingredient. The recombinant protein according to the present invention is a carrier capable of efficiently transferring a gene to the brain, which can be applied to the delivery of various nucleic acids including plasmid DNA and can be used for the treatment of various brain diseases. |
| priorityDate |
2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |